Head Office Novartis International AG CH-4002 Basel Switzerland
+41 61 324 11 11 +41 61 324 80 01 Monday - Friday, 8:30 - 17:00, GMT+1 (Central European Time)
More information
Novartis International AG Investor Relations P.O. Box CH-4002 Basel Switzerland
+41 61 324 79 44 investor.relations@novartis.com
Global Media Relations Eric Althoff Basel, Switzerland
+41 61 324 7999 eric.althoff@novartis.com
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
Reporting side effects
The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 13 members and Prof. Lehner acts as chairman effective Annual General Meeting 2013 until July 31.
Download the Novartis organizational structure (40 KB)
Ulrich Lehner, Ph.D.Chairman a.i.
Read biography:
Enrico Vanni, Ph.D.Vice Chairman
Dimitri Azar, M.D., MBA
Verena A. Briner, M.D.
William Brody, M.D., Ph.D.
Srikant Datar, Ph.D.
Ann Fudge
Pierre Landolt, Ph.D.
Andreas von Planta, Ph.D.
Charles L. Sawyers, M.D.
Dr. Ing. Wendelin Wiedeking
William T. Winters
Rolf M. Zinkernagel, M.D.
Charlotte Pamer-Wieser, Ph.D.
Back to top
Rankings and awards
Fact sheet
Associate videos
Corporate organizational structure (23 KB)
Novartis campus brochure (486 KB)
Connecting with patients brochure (512 KB)
Annual report 2012 >